Study examines effects of delaying treatment for ocular hypertension

Early treatment of ocular hypertension appears to reduce the risk of developing glaucoma, especially in individuals at the highest risk, according to a report in the March issue of Archives ...

Mon 8 Mar 10 from PhysOrg

Ocular Hypertension Treatment Options, Mon 8 Mar 10 from RedOrbit

Frost & Sullivan Recognizes Timoptic(R) (timolol maleate) as Best Brand Name Beta Blocker for Glaucoma: Timoptic Brand is Highest Rated in Survey of Ophthalmologists

LAWRENCEVILLE, N.J., March 4 /PRNewswire/ -- Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that in an independent survey of U.S. ophthalmologists by Frost ...

Thu 4 Mar 10 from RedOrbit